Determination of glycemic index of enteral formulas used in clinical practice

Glycemic Index (GI) is a measure of carbohydrate quality and is recognised as a valid and reproducible method of classifying carbohydrate foods according to its effects on postprandial glycaemia. In this randomised crossover trial (RBR-7rjx3k) we determined the GI of nine enteral formulas, following...

Full description

Saved in:
Bibliographic Details
Published in:International journal of food sciences and nutrition 2020-02, Vol.71 (2), p.201-210
Main Authors: Tosatti, Jéssica Abdo Gonçalves, Bocardi, Victória Bortolosso, Jansen, Ann Kristine, Bernandes, Hugo, Silva, Flávia Moraes
Format: Article
Language:English
Subjects:
enteral formulas
glycemic control
Glycemic index
glycemic load
glycemic response
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Glycemic Index (GI) is a measure of carbohydrate quality and is recognised as a valid and reproducible method of classifying carbohydrate foods according to its effects on postprandial glycaemia. In this randomised crossover trial (RBR-7rjx3k) we determined the GI of nine enteral formulas, following the Food and Agriculture Organisation/World Health Organisation method. Forty healthy participants were included in the study (85% female mean age 27.1 ± 6.7 years). GI of the enteral formulas ranged from 40.5 to 85.2; four formulas had high GI (Nutrienteral 1.5 ® , Novasource GI Control ® , Diamax ® , Isosource Soya ® ), two intermediate GI (Fresubin 1.2 HP Fibre ® , Nutrison Energy Multifiber 1.5 ® ) and three low GI (Trophic 1.5 ® , Glucerna ® , Novasource GC HP ® ). The GI coefficient of variation ranged from 22.9% to 83.6%. The effect of the enteral formulas with low GI in glycemic control of patients with enteral nutrition prescription needs to be test in future studies.
ISSN:0963-7486
1465-3478
DOI:10.1080/09637486.2019.1634011